Developing A Common Outcome Measure For Priority Setting In Health: Validation Of The 'Transfer To Utility' Technique
Funder
National Health and Medical Research Council
Funding Amount
$314,100.00
Summary
The economic evaluation of health programs is a common requirement of funders and purchasers seeking to get the best value from the health dollar. But researchers employ a wide range of disease specific and generic health status instruments to describe trial outcomes, making comparison between diverse interventions difficult. In response to this problem a 'Transfer to Utility' or TTU technique was developed by Dr Segal and colleagues, to translate diverse outcomes reported in clinical trials, in ....The economic evaluation of health programs is a common requirement of funders and purchasers seeking to get the best value from the health dollar. But researchers employ a wide range of disease specific and generic health status instruments to describe trial outcomes, making comparison between diverse interventions difficult. In response to this problem a 'Transfer to Utility' or TTU technique was developed by Dr Segal and colleagues, to translate diverse outcomes reported in clinical trials, into a utility score, so the performance of diverse health interventions can be expressed in cost-QALY and compared. The technique establishes a statistical transformation between instruments commonly used in clinical trials and a utility value. While the technique appears highly useful, based on a priority setting exercise in osteoarthritis enabling 20 disparate interventions to be compared its validity and applicability in other contexts is not established. The purpose of the grant is to explore the TTU technique to i) establish the best method for estimating the regression equation between common health outcome measures and a utility score and validating that method; ii) test generalisability to other disease areas, for which quality of life is the primary objective of management (in stroke, drug dependence and depression), iii) develop and validate a method for translating the most commonly used measure of general health status, the SF-36, into a utility score and iv) illustrate the application of the TTU in comparing intervensions for the prevention and management of depression. The results of the research will be of value to i) decision makers who must compare the performance of medical-health care interventions across a range of diseases and modalities and ii) to clinicians who want to practice evidenced based health care. The potential health gains for the community are substantial, in supporting the redirection of resources to more effective and cost-effectiveRead moreRead less
Development And Valuation Of Cancer-specific Multi-attribute Health States For Use In Economic Evaluation
Funder
National Health and Medical Research Council
Funding Amount
$707,671.00
Summary
Economic evaluation is used by the Australian government in deciding which medical services and pharmaceuticals should be funded. This study will develop quality of life utility measures for use in economic evaluation of cancer interventions in Australia and internationally. This represents a significant methodological contribution to the assessment of quality of life, effectiveness and efficiency in cancer, in one of Australia's national health priority areas.
Application Of Discrete Choice Experiments To Value Multi-attribute Health States For Use In Economic Evaluation
Funder
National Health and Medical Research Council
Funding Amount
$450,369.00
Summary
Economic evaluation is used increasingly by health care decision makers to decide which health care programs provide the best value for money, in terms of improving health and quality of life outcomes for the population. It is used by the Australian government in deciding which medical services and pharmaceuticals should be funded. This requires measurement of quality of life in a way that allows comparison across treatments, and a means of quantifying community preferences for different health ....Economic evaluation is used increasingly by health care decision makers to decide which health care programs provide the best value for money, in terms of improving health and quality of life outcomes for the population. It is used by the Australian government in deciding which medical services and pharmaceuticals should be funded. This requires measurement of quality of life in a way that allows comparison across treatments, and a means of quantifying community preferences for different health states (that is, how we value health outcomes). Health outcomes are often valued using the quality adjusted life year (QALY) which combines length and quality of life in a single measure. To compare across diseases and treatments, quality of life must be measured in the same way. This can be done by using a standard set of questions that cover the different aspects of quality of life (eg pain, mobility, emotional state). In this way, a single survey instrument can be used for any disease or outcome of treatment. We can also use the same instrument to ask members of the public to provide information about their preferences for different health states (that is how they value health outcomes). However, obtaining this information from respondents is complex, and there is debate about which are the best instruments, and the best methods to value health outcomes. In this research, we propose a new approach to valuing health states, which is easier to administer and which allows for more detailed and rigorous analysis of the responses people give, to provide better models of how the different aspects of quality of life are combined in valuing health outcomes. We will compare the new method with the main existing methods. We will compare these methods for two standard quality of life instruments that are widely used in health care research. The research will also provide valuations of health states from the Australian population that can then be used in economic evaluation.Read moreRead less
AusGo-SHEMO….Let’s Go! Australian Gold Standard Health Economics Model Of Osteoporosis
Funder
National Health and Medical Research Council
Funding Amount
$378,959.00
Summary
We will develop an unbiased, gold standard, validated, transparent health economics model of osteoporosis to identify cost-effective screening and treatment strategies, and that will be made widely available to all stakeholders. Without this model, scarce health care resources may be squandered on osteoporosis screening strategies and osteoporosis-related fracture prevention medications that are not cost-effective. Worse, patient access to cost-effective medications may be delayed.
The Economics Of Surgery: Using Routine And Registry Data To Improve Policy, With Particular Reference To Congenital Heart Disease (the Fontan Procedure) And Prosthetic Surgery (hip And Knee Replacements)
Funder
National Health and Medical Research Council
Funding Amount
$86,073.00
Summary
My research will use economics to help improve surgery outcomes. Clinical and policy recommendations in surgery often come from a relatively low evidence base. I will make use of detailed data registries of previous recipients of hip and knee surgery (St. Vincent’s Hospital Melbourne) and Fontan heart surgery (Royal Children’s Hospital Melbourne) to develop advanced economic models of surgery outcomes. My aim is to use these models to improve real-world health policies in surgery.
Modelling The Cost-effectiveness Of Therapeutic Strategies For Invasive Candidiasis Among The ICU Population
Funder
National Health and Medical Research Council
Funding Amount
$282,733.00
Summary
ICU patients are vulnerable to fungal infections during their stay in hospital. These infections are costly to treat and pose real dangers to the patient with up to 1270 lives lost each year. The best way to diagnose and treat these infections is currently not known. Making an early and accurate diagnosis is difficult but important if the infection is to be managed appropriately. This research will show which management strategies are optimal for patients and health services.
Economic Evaluation Of Policies To Manage And Prevent Cardiovascular Disease & Diabetes In Australia
Funder
National Health and Medical Research Council
Funding Amount
$713,517.00
Summary
This Research Fellowship will use health economics to deliver health system impact. It will focus on: (i) mechanisms for setting prices for generic pharmaceuticals in Australia; (ii) exploring the implications for optimal prescribing from reductions in prices of pharmaceuticals to prevent cardiovascular disease and other chronic diseases; (iii) developing health economic computer simulation models to guide the prevention and treatment of diabetes and cardiovascular disease.
Development And Validation Of A Health Policy Simulation Model For Type 1 Diabetes.
Funder
National Health and Medical Research Council
Funding Amount
$409,199.00
Summary
This proposal brings together an international multi-disciplinary team to develop and validate a health economic computer simulation model for type 1 diabetes and its complications. It examines the impact of diabetes on costs as well as quality of life. Outcomes generated by the model will inform health policy decisions regarding allocation of resources for people with type 1 diabetes such as cost-effectiveness analysis of new treatments and technologies.
Guiding Intervention Choices To Reduce Health Costs, Health Inequalities, And Improve The Health Of Australians
Funder
National Health and Medical Research Council
Funding Amount
$3,200,000.00
Summary
As health care costs rise, governments increasingly will need objective evidence on the benefits and costs of health intervention options, whilst taking into account the need for greater health equity, transparency of decision making and stakeholder acceptability. This project will provide the health intelligence to guide such health priority setting in Australia, with a focus on prevention of non-communicable diseases, the implications for Indigenous Australians and the most efficient ways of i ....As health care costs rise, governments increasingly will need objective evidence on the benefits and costs of health intervention options, whilst taking into account the need for greater health equity, transparency of decision making and stakeholder acceptability. This project will provide the health intelligence to guide such health priority setting in Australia, with a focus on prevention of non-communicable diseases, the implications for Indigenous Australians and the most efficient ways of implementing priority interventions in primary care.Read moreRead less
New Approaches To Describing And Valuing Quality Of Life
Funder
National Health and Medical Research Council
Funding Amount
$304,596.00
Summary
The ability of healthcare to improve quality of life is a major factor in determining public subsidy. This fellowship first explores patterns in Australian quality of life. This will identify groups with poor quality of life, and the remedying impact achieved under various interventions. It will then consider how people place value on aspects of quality of life. The two strands will allow linkage between important areas of quality of life and the policy impact of health interventions.